Saturday, June 14, 2025

Healthcare

Mangoceuticals (MGRX): Can MGRX Stimulate the Stock Market’s Morning Glory?

In the throes of a global economic downturn, investors are on the lookout for any sign of vitality in the stock market. Enter Mangoceuticals...

Mangoceuticals, Inc. (NASDAQ: MGRX) Secures Exclusive Rights to Diabetinol®, Entering $33.6 Billion Diabetes Market

Mangoceuticals, Inc. (NASDAQ: MGRX), operating as MangoRx, is a Dallas-based telemedicine company specializing in men's health and wellness. The company offers treatments for conditions...

MangoRx (NASDAQ: MGRX) Is Empowering Health and Wellness Through Innovation

MangoRx (NASDAQ: MGRX) is a health and wellness company dedicated to empowering individuals with effective solutions in key areas of personal well-being. The company...

NurExone Achieves 2025 TSX Venture 50™️ Milestone, Plans U.S. Growth and Beyond

(“NurExone” or the “Company”) (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) has been included in the 2025 TSX Venture 50™. For those living under a rock,...

NurExone: Pioneering Exosome Therapies for Vision and Spinal Cord Regeneration

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company developing exosome-based therapies for the multi-billion-dollar regenerative medicine market.  Among its...

Popular

Subscribe